Ledger. Australian venture funding, tracked

Startup · $23.1m raised · Healthcare

Ferronova

advance image-guided cancer surgery

Adelaide, SA

Coverage

Stories naming Ferronova. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

4 deals

Inside the Australian Life Sciences Boom: Renowned Investors, World-Class Partners, World-Leading Breakthroughs

Wholesale Investor's Steve Torso highlights Australian life sciences companies from the Emergence Preview Series, noting government grant funding, a Series A extension, venture co-investment, and a medtech company's ASX listing.

Also Wholesale Investor

11 deals

Seven ANZ startups that raised $93.1 million this week

Roundup of seven trans-Tasman raises worth $93.1m this week, headlined by IND Technology's $50m round, with LawVu also acquiring ClauseBase.

Also Startup Daily·Startup Daily

2 deals

Biotech Ferronova boosts Series A capital raise by $6m

Adelaide biotech Ferronova added $6 million to its Series A from prior backers, lifting the round's total to $17.5 million; backer Renew's parent Ultragreen.ai floated in Singapore this month.

Also ferronova.com.au·movefm.com.au·Biotech Dispatch·Startup Daily

4 deals

These Aussie startups raised a cool $29 million this week

Weekly roundup covering three Australian raises: Rumin8's climate tech funding led by Breakthrough Energy Ventures, Ferronova's biotech round led by Renew Pharmaceuticals, and EMVision's stroke imaging milestone payment.

2 deals

‘No tumour will go undetected’: Ferronova lands $11 million for its cancer hunting nanotechnology

Adelaide biotech Ferronova raised $11 million for its cancer-detection nanotechnology, with Renew Pharmaceuticals and a government CRC contributing, following an earlier $4.6 million Series A in 2020.

Also SmartCompany

2 deals

South Australian biotech startup Ferronova banks $11 million to tackle cancer treatment

Adelaide cancer-focused biotech Ferronova has secured fresh backing: an investor round led by Irish strategic partner Renew Pharmaceuticals plus a federal research grant, to speed clinical trials in stomach and brain cancers.

Also SmartCompany·SmartCompany·Startup Daily·Business News Australia·Startup Daily

Funding announcement

Ferronova secures $3.5m Series A funding led by Uniseed

Cancer-detection nanotech developer Ferronova announced a $3.5 million Series A round, with Uniseed leading, to fund planned human trials across several cancer types; research partners span four universities.

Something wrong? Tell us